PRR.ASX

Prima Biomed LTD

Ord Minnett View

You need to become a client or login to see Forsyth Barr’s current view.

About Prima Biomed LTD

Prima BioMed Ltd (PRR) is a global biotechnology company headquartered in Australia. PRR focuses on personalised bio-therapeutic products for cancer. Its lead product is CVac, an autologous dendritic cell-based product currently in clinical trials for ovarian cancer patients who are in remission. PRR also develops an oral vaccine against Human Papilloma Virus (HPV).

Latest Prima Biomed LTD news Show more news

If you're new to investing or just have a question please call us: 0800 367 227